Diaceutics PLC (DXRX)

Diaceutics PLC experienced three recent buy transactions totaling 446.4 GBP. Key executives, including the Chief Finance Officer, Chief Data Officer, and Chief Precision Medicine Officer, acquired shares on July 31, 2026. These purchases occurred following the company's May earnings report, amidst a 2.4% stock price increase over the last ninety days.
Ticker: DXRX Exchange: LSE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Diaceutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Nick Roberts Chief Finance Officer Officer
Transaction date
Purchase
Price
73.56
Quantity 69,882
Value £536,395
3.6
Jordan Clark Chief Data Officer Officer
Transaction date
Purchase
Price
88.39
Quantity 50,122
Value £3,438,144
1.8
Susanne Munksted Chief Precision Medicine Officer Officer
Transaction date
Purchase
Price
355.00
Quantity 73,620
Value £3,391,116
2.7
Nick Roberts Chief Finance Officer Officer
Transaction date
Purchase
Price
1.67
Quantity 90
Value £150
3.6
Jordan Clark Chief Data Officer Officer
Transaction date
Purchase
Price
1.67
Quantity 90
Value £150
2.7
Nick Roberts Chief Finance Officer Officer
Transaction date
Purchase
Price
1.49
Quantity 100
Value £149
3.6
Jordan Clark Chief Data Officer Officer
Transaction date
Purchase
Price
1.49
Quantity 100
Value £149
1.8
Susanne Munksted Chief Precision Medicine Officer Officer
Transaction date
Purchase
Price
1.49
Quantity 100
Value £149
3.0
Graham Paterson Non-Executive Director Executive Director
Transaction date
Purchase
Price
1.29
Quantity 39,934
Value £51,471
0.8
Transaction date
Sale
Price
1.02
Quantity 750,000
Value £765,000
0.8
Peter Keeling Executive Director Executive Director
Transaction date
Sale
Price
1.02
Quantity 750,000
Value £765,000
3.0
Graham Patterson Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.99
Quantity 33,564
Value £33,061
2.7
Nick Roberts CFO Officer
Transaction date
Purchase
Price
0.92
Quantity 21,742
Value £19,948
3.6
Jordan Clark Chief Commercial Officer Officer
Transaction date
Sale
Price
0.98
Quantity 50,000
Value £49,000
3.6
Jordan Clark Chief Commercial Officer Officer
Transaction date
Sale
Price
1.02
Quantity 3,000
Value £3,060
3.6
Jordan Clark Chief Commercial Officer Officer
Transaction date
Sale
Price
1.05
Quantity 100,000
Value £104,500
3.0
Philip White PDMR
Transaction date
Sale
Price
0.98
Quantity 140,000
Value £137,200
3.0
Philip White PDMR
Transaction date
Sale
Price
1.01
Quantity 60,000
Value £60,600
1.6
Charles Hindson Non-Executive Director Executive Director
Transaction date
Purchase
Price
1.01
Quantity 20,000
Value £20,200
3.2
Deborah Davis Chair Director
Transaction date
Purchase
Price
1.02
Quantity 5,000
Value £5,100
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-04 2026-07-31 B Purchase

Chief Finance Officer

Officer
69,882
73.56
£536,395
69,882 73.56 £536,395
2026-08-04 2026-07-31 B Purchase

Chief Data Officer

Officer
50,122
88.39
£3,438,144
50,122 88.39 £3,438,144
2026-08-04 2026-07-31 B Purchase

Chief Precision Medicine Officer

Officer
73,620
355.00
£3,391,116
73,620 355.00 £3,391,116
2026-05-05 2026-04-30 B Purchase

Chief Finance Officer

Officer
90
1.67
£150
90 1.67 £150
2026-05-05 2026-04-30 B Purchase

Chief Data Officer

Officer
90
1.67
£150
90 1.67 £150
2026-04-01 2026-03-30 B Purchase

Chief Finance Officer

Officer
100
1.49
£149
100 1.49 £149
2026-04-01 2026-03-30 B Purchase

Chief Data Officer

Officer
100
1.49
£149
100 1.49 £149
2026-04-01 2026-03-30 B Purchase

Chief Precision Medicine Officer

Officer
100
1.49
£149
100 1.49 £149
2024-05-23 2024-05-22 B Purchase

Non-Executive Director

Executive Director
39,934
1.29
£51,471
39,934 1.29 £51,471
2024-04-02 2024-03-28 S Sale

PCA

750,000
1.02
£765,000
750,000 1.02 £765,000
2024-04-02 2024-03-28 S Sale

Executive Director

Executive Director
750,000
1.02
£765,000
750,000 1.02 £765,000
2024-03-07 2024-03-06 B Purchase

Non-Executive Director

Executive Director
33,564
0.99
£33,061
33,564 0.99 £33,061
2023-06-06 2023-06-05 B Purchase

CFO

Officer
21,742
0.92
£19,948
21,742 0.92 £19,948
2023-05-11 2023-05-04 S Sale

Chief Commercial Officer

Officer
50,000
0.98
£49,000
50,000 0.98 £49,000
2023-05-04 2023-04-28 S Sale

Chief Commercial Officer

Officer
3,000
1.02
£3,060
3,000 1.02 £3,060
2023-04-26 2023-04-21 S Sale

Chief Commercial Officer

Officer
100,000
1.05
£104,500
100,000 1.05 £104,500
2022-04-07 2022-04-06 S Sale

PDMR

140,000
0.98
£137,200
140,000 0.98 £137,200
2022-04-07 2022-04-06 S Sale

PDMR

60,000
1.01
£60,600
60,000 1.01 £60,600
2022-04-07 2022-04-06 B Purchase

Non-Executive Director

Executive Director
20,000
1.01
£20,200
20,000 1.01 £20,200
2022-04-07 2022-04-06 B Purchase

Chair

Director
5,000
1.02
£5,100
5,000 1.02 £5,100